Relation is an innovative player in the Biotechnology and Pharmaceutical sectors, based in the United Kingdom. Founded in 2019, this company is on the cutting edge of biotech, combining high-resolution biological insights with advanced machine learning techniques to pioneer new therapeutic solutions for complex diseases.
The company lives by its slogan: "Discovering the relationships at the heart of biology to cure disease." By integrating multi-omics data, single-cell analysis, and functional assays, Relation has developed a proprietary "Lab-in-the-Loop" technology, which allows them to efficiently identify druggable targets and accelerate the development of transformational medicines.
In a noteworthy milestone, Relation raised a $55.00M Late VC investment on 01 December 2025, led by the pharmaceutical giant Novartis. This funding signifies strong investor confidence in their groundbreaking approach to biotech and pharmaceuticals, boosting their potential to make significant advancements in disease understanding and therapy development.